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G-protein coupled receptors (GPCRs) are the largest family of membrane sig-
naling proteins. They respond to a wide-array of stimuli and contain a seven
transmembrane domain that couples to heterotrimeric G-proteins. These path-
ways play roles in controlling second messenger levels and regulating other
signaling proteins, such as ion channels and kinases. Due to their importance
in many diseases, GPCRs are the most explored drug targets in biology. De-
spite this, the specific biochemical, physiological, and behavioral roles of
many GPCRs are not well-understood and make this field ripe for the applica-
tion of new tools for high-precision probing. We have developed an approach
to elucidate the function of a GPCR by chemically re-engineering it to be sen-
sitive to light. The class C glutamate-gated GPCR, mGluR2, which couples to
the Gi/o pathway, was derivatized with photoswitchable ligands to generate
both light-agonized (LimGluR2) and light-antagonized (‘‘LimGluR2-block’’)
receptors. The bistable, azobenzene photoswitch enables activation by a light
pulse to be sustained for long periods in the dark before being switched off by
a longer wavelength light pulse. LimGluR2 deactivates quickly and supports
multiple reproducible rounds of on/off switching with superior fidelity and
speed compared to Rhodopsin. We have extended optical control to a variety
of mGluRs with distinct G-protein coupling profiles. These designed receptors
provide excellent tools for the dissection of the specific roles of different
mGluRs in physiological functions, such as induction of synaptic plasticity,
with high spatiotemporal precision. Furthermore, the high level of control af-
forded by tethered agonists allows for the probing of coupling of ligand-
binding to receptor activation with single-subunit control. Along with
single-molecule fluorescence experiments, we have used optical control via
LimGluRs to probe the mechanisms of assembly and cooperative activation
in the class C GPCRs.
2635-Pos Board B405
Deciphering the Cross-Talk of the Prostaglandin G-Protein Coupled
Receptors EP2 and EP4: From Molecular Insights to Novel Anti-Tumor
Targets
Sandra de Keijzer1, Samantha L. Schwartz2, Mark M. Rasenick3,
Carl G. Figdor1, Vinod Subramaniam4, Diane S. Lidke2, Alessandra Cambi1.
1Radboud University Nijmegen MC, Nijmegen, Netherlands, 2University of
New Mexico, Albuquerque, NM, USA, 3University of Illinois at Chicago,
Chicago, IL, USA, 4University of Twente, Enschede, Netherlands.
Prostaglandin E2 (PGE2) favors cancer progression by promoting angiogenesis
and metastasis, and by influencing the immune response, thus being a key tu-
morigenic factor. The specificity and diversity of PGE2 effects can be ex-
plained by cells expressing a characteristic pattern of different EP receptors
with distinctive signaling mechanisms. PGE2 signaling through both EP2
and EP4 receptors coupled to the G-protein Gas is known to stimulate
cAMP production. Interestingly, although details of the down-stream signaling
pathways remain unknown, increasing evidence suggests that EP4 also couples
to Gai, which is known to inhibit cAMP production, thus triggering a natural
inhibitory pathway. We aim to unravel the dynamics and molecular mecha-
nisms of the cross-talk of EP2 and EP4 receptors via the inhibitory Gai and
the stimulatory Gas signaling axis at the molecular level. FRAP and FLIM
studies confirmed that only EP4 signals via Gai and showed that although
the intitiation of PGE2-induced Gas and Gai signaling occurs simultaneously,
Gas signals longer than Gai. Single-particle tracking of q-dot labeled receptors
revealed that EP4 slows down upon PGE2 stimulation whereas EP2 only de-
creases mobility when EP4 is present, suggesting cross talk. Furthermore, using
a cAMP FRET-sensor we were able to investigate the extent of cAMP produc-
tion using EP2 and EP4 specific agonist/antagonist and showed that EP4 signal-
ing caused a transient cAMP response. We propose a model where EP4 allows
for the fine-tuning of the cell’s response to PGE2, providing a threshold for
a cell to respond to PGE2, whereas EP2 continuously signals to high levels
of PGE2. We believe that targeting PGE2 signaling and control the outcomeof the cell’s response to PGE2 will provide new tools for the development of
alternative therapeutic approaches to cancer treatment.
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The lower liability of atypical antipsychotics to produce side-effects corre-
lates with their faster rates of dissociation from the dopamine D2 receptor.
Recent studies indicate that the novel D2 ligands, ACR16 and OSU6162,
act as antagonists with similarly high dissociation rates. However, those
studies measured dissociation of radiolabeled ligand from membrane prepa-
rations or used modified G proteins to study calcium release. We examined
relative antagonist dissociation rates in living cells, using a time-resolved as-
say based on activation of G protein-coupled potassium channels (GIRK) by
native G proteins. GIRK responses to dopamine receptor activation were
studied using two-electrode voltage clamp in Xenopus oocytes expressing
D2 receptors and GIRK. First, dopamine was applied, resulting in a ‘‘base-
line’’ response. Next, antagonist was washed in, in the continued presence
of dopamine. After attaining steady-state response inhibition, antagonist
was washed out, still in the presence of dopamine. Response recovery
was recorded over six minutes, and the time-course and relative amplitude
of recovery were taken as measures of antagonist dissociation. Significant
differences in response recovery T1/2 and recovery amplitudes were ob-
served between the different D2 receptor antagonists: In experiments with
haloperidol, risperidone, and aripiprazole, virtually no response recovery
was observed. With clozapine and quetiapine, similar recovery amplitudes
and recovery time courses were observed (T1/2 ~ 40 s). ACR16 and
OSU6162 behaved as antagonists, lacking detectable efficacy in the GIRK
assay. These compounds washed out with similar time courses (T1/2 ~ 8
s); significantly faster than the other antagonists. ACR16 and OSU6162 ap-
pear to dissociate faster than clozapine and quetiapine, a finding which has
not been reported earlier. Such very rapid dissociation might be relevant to
the low incidence of side effects reported from clinical trials with these
compounds.
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G protein-coupled receptors (GPCRs) are proteins that span the cell mem-
brane seven times. They are stimulated by extracellular agonists and acti-
vate heterotrimeric G proteins to elicit intracellular responses. Recent
evidence suggests that GPCRs are voltage-sensitive: They exhibit gating
currents similar to ion channels and respond to depolarization of the plasma
membrane with changes in agonist affinity. We used a FRET-based biosen-
sor of the a2A adrenergic receptor to analyze voltage dependence of recep-
tor activation in HEK 293 cells by means of voltage-clamp recording. The
biosensor was stimulated either with the partial agonist clonidine or with
the full agonist norepinephrine (NE) and receptor activation was measured
as decrease in FRET ratio. Receptor stimulation by NE was reduced by
membrane depolarization and enhanced by hyperpolarization. This effect
was present in wilde-type receptors and transduced to the level of G protein
activation, which we determined in a FRET assay that directly detects Gai
protein activation. Depolarization-mediated inhibition of NE activated re-
ceptors was strong at low concentrations (500 nM: 60 % inhibition) but al-
most undetectable at saturating agonist concentrations (100 mM: 9 %
inhibition). Both agonist-induced and hyperpolarization-induced receptor ac-
tivation exhibited a similar monoexponential time course. For both activa-
tion modes, speed of activation was primarily dependent on agonist
concentration, indicating that depolarization lowers the apparent affinity
of the NE receptor interaction and thus causes receptor deactivation by
means of NE release. Application of clonidine (1 mM, VM=-90 mV) re-
sulted in a FRET response that was inhibited by 40 % at þ60 mV. In con-
trast to NE, strong receptor-inhibition at þ60 mV was present even at
super-saturating concentrations of clonidine (100 mM). Therefore we con-
clude that negative membrane potentials promote active conformations of
the a2A adrenergic receptor, increase affinity of full agonists and enhance
G protein signaling.
